Labs In Court: A roundup of recent cases and enforcement actions involving the diagnostics industry
...
Already a member? Log in here
PAMA Reimbursement: CMS Tells Labs How to Secure ADLT Status for New Tests
From - G2 Compliance Advisor
Although the 2018 market-based Clinical Laboratory Fee Schedule (CLFS) is officially in effect, implementation of the new…
Already a member? Log in here
Getting Paid: Medicare to Cover Next Gen-Sequencing Tests for Advanced Cancer
...
Already a member? Log in here
Case of the Month: $11.4 Million Natera Settlement Shows Genetic Billing & Coding Remains a False Claims Hot Button
From - G2 Compliance Advisor
Before the opioid crackdown, false billing of genetic tests was the hottest thing in federal fraud enforcement against clinical labs. But while drug testing related to…
Already a member? Log in here
Case of the Month: Feds Turn Up the Heat on False Billing of Nuclear Stress Tests
From - G2 Compliance Advisor
While the feds have made urine drug testing of opioid drug patients their number one target for lab-related False Claims Act (FCA) charges this year, nuclear stress tests …
Already a member? Log in here